"Drug Combinations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
Descriptor ID |
D004338
|
MeSH Number(s) |
D26.310
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Combinations".
Below are MeSH descriptors whose meaning is more specific than "Drug Combinations".
- Drug Combinations
- Adapalene, Benzoyl Peroxide Drug Combination
- Albuterol, Ipratropium Drug Combination
- Aminophylline
- Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
- Amlodipine, Valsartan Drug Combination
- Aspirin, Dipyridamole Drug Combination
- Biphasic Insulins
- Brimonidine Tartrate, Timolol Maleate Drug Combination
- Budesonide, Formoterol Fumarate Drug Combination
- Buprenorphine, Naloxone Drug Combination
- Contraceptives, Oral, Combined
- Dimenhydrinate
- Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Emtricitabine, Rilpivirine, Tenofovir Drug Combination
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Ezetimibe, Simvastatin Drug Combination
- Fluticasone-Salmeterol Drug Combination
- Mometasone Furoate, Formoterol Fumarate Drug Combination
- Multi-Ingredient Cold, Flu, and Allergy Medications
- Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination
- Trimethoprim, Sulfamethoxazole Drug Combination
This graph shows the total number of publications written about "Drug Combinations" by people in this website by year, and whether "Drug Combinations" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 5 | 5 |
1996 | 0 | 3 | 3 |
1997 | 0 | 2 | 2 |
1998 | 0 | 3 | 3 |
2000 | 0 | 5 | 5 |
2001 | 0 | 2 | 2 |
2002 | 0 | 3 | 3 |
2003 | 0 | 4 | 4 |
2004 | 0 | 2 | 2 |
2005 | 0 | 6 | 6 |
2006 | 0 | 6 | 6 |
2007 | 0 | 11 | 11 |
2008 | 0 | 3 | 3 |
2009 | 0 | 7 | 7 |
2010 | 0 | 8 | 8 |
2011 | 0 | 6 | 6 |
2012 | 0 | 7 | 7 |
2013 | 0 | 5 | 5 |
2014 | 0 | 6 | 6 |
2015 | 0 | 3 | 3 |
2016 | 0 | 8 | 8 |
2017 | 0 | 9 | 9 |
2018 | 1 | 10 | 11 |
2019 | 0 | 9 | 9 |
2020 | 0 | 13 | 13 |
2021 | 0 | 9 | 9 |
2022 | 0 | 10 | 10 |
2023 | 0 | 4 | 4 |
2024 | 4 | 6 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Combinations" by people in Profiles.
-
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec; 13(1):2421397.
-
SUPPLEMENTAL DEXTROSE IN THE INFUSION FLUID DURING DIABETIC VITRECTOMY. Retina. 2024 11 01; 44(11):1931-1936.
-
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
-
In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2024 Sep; 38:252-255.
-
Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder. Eur Neuropsychopharmacol. 2024 Sep; 86:18-19.
-
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults. Clin Infect Dis. 2024 Jun 14; 78(6):1757-1768.
-
In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d. Ann Intern Med. 2024 Jun; 177(6):JC67.
-
The national financial burden of guideline directed medical therapy for heart failure patients from 2013 to 2021. Curr Probl Cardiol. 2024 Aug; 49(8):102684.
-
Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. J Allergy Clin Immunol Pract. 2024 Sep; 12(9):2372-2380.e5.
-
Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1342-1354.